Drugs.com
FEBRUARY 20, 2025
THURSDAY, Feb. 20, 2025 -- Social media often tempts teenagers with non-surgical ways to improve their appearance, such as laser hair removal, skin and teeth whitening, chemical peels, botox, and face and lip fillers.And a new poll finds that a.
Covalent Modifiers
FEBRUARY 21, 2025
Teresa Marker, Raphael R. Steimbach, Cecilia Perez-Borrajero, Marcin Luzarowski, Eric Hartmann, Sibylle Schleich, Daniel Pastor-Flores, Elisa Espinet, Andreas Trumpp, Aurelio A. Teleman, Frauke Grter, Bernd Simon, Aubry K. Miller & Tobias P. Dick Nat. Chem. ( 2025 ). [link] Proton pump inhibitors have become top-selling drugs worldwide. Serendipitously discovered as prodrugs that are activated by protonation in acidic environments, proton pump inhibitors inhibit stomach acid secretion by cov
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
FEBRUARY 21, 2025
Researchers have applied a visualization technique to depict the brain's activity related to visual perception as geometric patterns. They visualized different shapes as the ever-changing neuronal activity in the temporal and frontal lobes of the brain during object recognition and recalling memories. This achievement promises further extraction of brain activity observed in various aspects of daily life.
Alta Sciences
FEBRUARY 19, 2025
Regulatory Guidance for Oligonucleotide Bioanalysis in Drug Development pmjackson Wed, 02/19/2025 - 21:30 The unique physicochemical properties of oligonucleotides require the use of specialized bioanalytical approaches, with key considerations including selectivity and specificity, sensitivity, stability, and matrix effects. Addressing these factors means bioanalytical methods can effectively differentiate oligonucleotides from endogenous nucleic acids and metabolites, quantify low concentratio
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
FDA Law Blog: Biosimilars
FEBRUARY 18, 2025
By Richard A. Lewis, , Principal Regulatory Device and Biologics Expert The FDA is currently funded through March 1st, 2025. Come Monday March 3rd, if Congress does not pass a budget or continuing resolution, the FDA will enter a shutdown and shutter many offices and programs while Congress works out their inter-party squabbles on national priorities.
Perficient: Drug Development
FEBRUARY 19, 2025
Sitecore Personalize uses goals to track the performance of experiences and experiments. But what happens if your experience is live and you dont see any executions or goals tracked in the performance tab for the experience? It can be hard to debug, test and troubleshoot goal tracking especially if the experience is hidden behind a login for example.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug Patent Watch
FEBRUARY 19, 2025
The Unsung Heroes of Generic Drugs: The Importance of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the behind-the-scenes efforts that ensure the quality and safety of the medications we rely on. But today, I want to shine a spotlight on the often-overlooked heroes of the generic drug industry: Quality Assurance (QA) professionals.
FDA Law Blog: Biosimilars
FEBRUARY 18, 2025
By Andrew J. Hull A recent DEA decision revoking the registration of a Louisiana pharmacy sheds light on the Agencys approach to crediting one experts testimony over that of another expert during an administrative hearing. The discussion of the Agencys expectations of the form and substance of expert witness testimony is a must-read for entities or individuals facing a DEA order to show cause hearing.
Perficient: Drug Development
FEBRUARY 19, 2025
“Data is everywhereso how do we make it work for us?” Imagine walking into your favorite store, and before you even reach the counter, your phone buzzes with a personalized discount for an item you’ve been eyeing. This isnt the futureits happening now. Adobe and Perficient are revolutionizing digital experiences, making personalization smarter, faster, and more intuitive.
Antidote
FEBRUARY 18, 2025
Clinical trials are fundamental to the development of new therapies, but engaging patients effectively remains one of the most significant challenges for research organizations. As competition among similar trials intensifies, understanding patient expectations and preferences has never been more important. For stakeholders in the clinical trial ecosystem, aligning recruitment and retention strategies with these insights can not only drive patient enrollment but also improve retention rates and
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
FEBRUARY 18, 2025
Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the fight against high healthcare costs. These highly similar versions of biologic medications offer a more affordable alternative to their reference products, but their development requires careful consideration of regulatory requirements.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Researchers have found that stars in the early universe may have formed from 'fluffy' molecular clouds. Using the ALMA telescope to observe the Small Magellanic Cloud -- whose environment is similar to the early universe -- they observed that about 60% of the observed clouds had the common filamentary structure, while the remaining 40% had a 'fluffy' shape.
FDA Law Blog: Biosimilars
FEBRUARY 20, 2025
By Allyson B. Mullen & Jeffrey N. Gibbs The multi-decade battle over FDAs power to regulate Laboratory Developed Tests (LDTs) had its day in court earlier this week. On February 19, 2025, Judge Sean Jordan in the Eastern District of Texas heard oral arguments in American Clinical Laboratory Association (ACLA) and the Association for Molecular Pathologys (AMP) [1] lawsuit against the Department of Health and Human Services.
Drug Channels
FEBRUARY 18, 2025
Abracadabra! Small pharmacies have ghosted Medicare Part Ds preferred networksno farewell party, no breakup text, just a quiet exit. A few months ago , DCI highlighted how the largest pharmacy chains are participating as preferred cost sharing pharmacies in the 2025 stand-alone prescription drug plan (PDP) networks. Today, we update our exclusive analysis of how smaller pharmacies are participating via their pharmacy services administrative organizations (PSAOs).
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
FEBRUARY 17, 2025
Unlocking the Path to Affordable Medications: A Step-by-Step Guide to Generic Drug Approval As a healthcare professional or a patient advocate, you're likely no stranger to the importance of affordable medications. But have you ever wondered what it takes for a generic drug to hit the market? The journey to approval is often shrouded in mystery, but it's a crucial process that affects millions of people worldwide.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Fetal acetaminophen exposure increases the likelihood that a child will develop attention-deficit/hyperactivity disorder (ADHD), according to a new study.
BioPharma Drive: Drug Pricing
FEBRUARY 21, 2025
The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of what it was once worth years ago.
Collaborative Drug
FEBRUARY 21, 2025
CDD Update February 2025 #2 New Macromolecule Mode Edit DNA, RNA & Peptides with Bioconjugate Support
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Patent Watch
FEBRUARY 20, 2025
The Unseen Heroes of the Pharmaceutical Industry: Achieving High-Quality Standards in Generic Drugs As we navigate the complex world of healthcare, it's easy to overlook the unsung heroes who work tirelessly behind the scenes to bring affordable, high-quality medications to the masses. I'm talking about the generic drug manufacturers who play a vital role in making life-saving treatments accessible to people worldwide.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
A little movement could help prevent dementia, even for frail older adults, suggests a new study.
BioPharma Drive: Drug Pricing
FEBRUARY 20, 2025
The $160 million acquisition of a FibroGen subsidiary expands AstraZeneca’s foothold in China while the company works through government investigations into its business practices there.
Drugs.com
FEBRUARY 20, 2025
THURSDAY, Feb. 20, 2025 -- Two indoor cats in Oregon were euthanized after contracting bird flu, leading to a recall of raw pet food sold in both Oregon and Washington, health officials have announced. The cats were from separate households and had.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
SugarCone Biotech
FEBRUARY 16, 2025
There were waves of interest in this therapeutic space at ASCO in June 2024 and around the JP Morgan healthcare conference in January 2025. Here we take a look at the hope and the hype behind the PD1/VEGF bispecific therapeutics.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Narcissists feel ostracized more frequently than their less self-absorbed peers, according to researchers. This may stem not only from being shunned due to their personalities but from a tendency to misinterpret ambiguous social signals as exclusion.
BioPharma Drive: Drug Pricing
FEBRUARY 20, 2025
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf.
Drugs.com
FEBRUARY 21, 2025
FRIDAY, Feb. 21, 2025 -- The health benefits of aggressive blood pressure control outweigh the potential risks for seniors, according to the latest results from a major clinical trial.About 85% of seniors treated to a target blood pressure of 120.
Fierce BioTech
FEBRUARY 20, 2025
In a recent interview with Fierce Biotech's Chris Hayden, Fortrea's Chief Technology and Data Officer Alaric Jackson discussed the growing role of AI in clinical trials. | Fortrea's CTO discusses AI's expanding role in clinical trials, from discovery to execution, and its potential to improve patient outcomes and diversity.
Science Daily: Pharmacology News
FEBRUARY 20, 2025
Large birds -- our closest relations to dinosaurs -- are capable of technical innovation, by solving a physical task to gain access to food.
BioPharma Drive: Drug Pricing
FEBRUARY 21, 2025
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a competing bid for Acelyrin and Intra-Cellular sales rose.
Drugs.com
FEBRUARY 18, 2025
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), according to a press release from.
Fierce BioTech
FEBRUARY 19, 2025
| Avoid common pitfalls in EU orphan drug market accesslearn how local expertise can help navigate pricing, reimbursement, and regulatory hurdles.
Science Daily: Pharmacology News
FEBRUARY 21, 2025
Researchers are blurring the lines between robotics and materials, with a proof-of-concept material-like collective of robots with behaviors inspired by biology.
Expert insights. Personalized for you.
Let's personalize your content